Search Page

1

Cite

Share

Biotransformation of irbesartan in man.

Chando TJ, Everett DW, Kahle AD, Starrett AM, Vachharajani N, Shyu WC, Kripalani KJ, Barbhaiya RH. Chando TJ, et al. Drug Metab Dispos. 1998 May;26(5):408-17. Drug Metab Dispos. 1998. PMID: 9571222 Clinical Trial.

Cite

Share

2

Cite

Share

Biotransformation of pravastatin sodium in humans.

Everett DW, Chando TJ, Didonato GC, Singhvi SM, Pan HY, Weinstein SH. Everett DW, et al. Among authors: chando tj. Drug Metab Dispos. 1991 Jul-Aug;19(4):740-8. Drug Metab Dispos. 1991. PMID: 1680649 Clinical Trial.

Cite

Share

3

Cite

Share

Hydroxylation of 14-C-niflumic acid by phenobarbital-induced rat liver microsomes.

Lan SJ, Chando TJ, Schreiber EC. Lan SJ, et al. Among authors: chando tj. Drug Metab Dispos. 1975 Mar-Apr;3(2):96-103. Drug Metab Dispos. 1975. PMID: 236165

Cite

Share

4

Cite

Share

Development and evaluation of a multiple-plate fraction collector for sample processing: application to radioprofiling in drug metabolism studies.

Barros A Jr, Ly VT, Chando TJ, Ruan Q, Donenfeld SL, Holub DP, Christopher LJ. Barros A Jr, et al. Among authors: chando tj. J Pharm Biomed Anal. 2011 Apr 5;54(5):979-86. doi: 10.1016/j.jpba.2010.11.029. Epub 2010 Nov 27. J Pharm Biomed Anal. 2011. PMID: 21168298

Cite

Share

5

Cite

Share

Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.

Lan SJ, Chando TJ, Weliky I, Schreiber EC. Lan SJ, et al. Among authors: chando tj. J Pharmacol Exp Ther. 1973 Aug;186(2):323-30. J Pharmacol Exp Ther. 1973. PMID: 4719785 No abstract available.

Cite

Share

6

Cite

Share

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.

Zhang D, Chando TJ, Everett DW, Patten CJ, Dehal SS, Humphreys WG. Zhang D, et al. Among authors: chando tj. Drug Metab Dispos. 2005 Nov;33(11):1729-39. doi: 10.1124/dmd.105.005447. Epub 2005 Aug 23. Drug Metab Dispos. 2005. PMID: 16118329

Cite

Share

7

Cite

Share

Percutaneous absorption of [3H]tretinoin and systemic exposure to mequinol after dermal application of 2% mequinol/0.01% [3H]tretinoin (Solagé) solution in healthy volunteers.

Everett DW, Franz TJ, Chando TJ, Gale PJ, Lehman PA, Schwarzel EH, Parab PV, D'Arienzo CJ, Kripalani KJ. Everett DW, et al. Among authors: chando tj. Biopharm Drug Dispos. 1999 Sep;20(6):301-8. doi: 10.1002/(sici)1099-081x(199909)20:6<301::aid-bdd189>3.0.co;2-5. Biopharm Drug Dispos. 1999. PMID: 10701701

Cite

Share

8

Cite

Share

Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers.

Vachharajani NN, Shyu WC, Chando TJ, Everett DW, Greene DS, Barbhaiya RH. Vachharajani NN, et al. Among authors: chando tj. J Clin Pharmacol. 1998 Aug;38(8):702-7. doi: 10.1002/j.1552-4604.1998.tb04809.x. J Clin Pharmacol. 1998. PMID: 9725545 Clinical Trial.

Cite

Share

9

Cite

Share

Metabolism of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey.

Lan SJ, Chando TJ, Cohen AI, Weliky I, Schreiber EC. Lan SJ, et al. Among authors: chando tj. Drug Metab Dispos. 1973 Jul-Aug;1(4):619-27. Drug Metab Dispos. 1973. PMID: 4149635 No abstract available.

Cite

Share